What is a Value Stock?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Pfizer PFE - P/E: 7.69
- First Wave BioPharma FWBI - P/E: 0.01
- Sensus Healthcare SRTS - P/E: 7.76
- Agile Therapeutics AGRX - P/E: 0.03
- Revelation Biosciences REVB - P/E: 0.02
Pfizer has reported Q1 earnings per share at $1.23, which has increased by 7.89% compared to Q4, which was 1.14. Its most recent dividend yield is at 4.17%, which has increased by 1.0% from 3.17% in the previous quarter.
First Wave BioPharma has reported Q4 earnings per share at $-9.47, which has decreased by 151.24% compared to Q3, which was 18.48. Most recently, Sensus Healthcare reported earnings per share at $-0.12, whereas in Q4 earnings per share sat at $0.17. This quarter, Agile Therapeutics experienced an increase in earnings per share, which was $-9.0 in Q4 and is now $-7.76. Revelation Biosciences saw an increase in earnings per share from -1.77 in Q4 to $-0.51 now.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.